| 0 |
ANTICONVULSANT DRUG LEVEL THERAPEUTIC |
3 |
0.3750 |
| 1 |
NATURAL KILLER CELL ACTIVITY ABNORMAL |
1 |
0.1667 |
| 2 |
NEW ONSET REFRACTORY STATUS EPILEPTICUS |
11 |
0.1000 |
| 3 |
NEONATAL OVERSEDATION |
2 |
0.0741 |
| 4 |
POSTHAEMORRHAGIC HYDROCEPHALUS |
4 |
0.0690 |
| 5 |
DOUBLE INLET LEFT VENTRICLE |
1 |
0.0526 |
| 6 |
SELENIUM DEFICIENCY |
2 |
0.0476 |
| 7 |
MECONIUM ILEUS |
3 |
0.0455 |
| 8 |
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME |
1 |
0.0323 |
| 9 |
MACROPHAGE ACTIVATION |
1 |
0.0294 |
| 10 |
XANTHOCHROMIA |
1 |
0.0278 |
| 11 |
SENSORY PROCESSING SENSITIVITY |
1 |
0.0227 |
| 12 |
LEUKAEMIC INFILTRATION PULMONARY |
1 |
0.0217 |
| 13 |
CORTICAL VISUAL IMPAIRMENT |
1 |
0.0172 |
| 14 |
THROAT LESION |
11 |
0.0161 |
| 15 |
INTRACRANIAL INFECTION |
2 |
0.0160 |
| 16 |
OVARIAN FIBROMA |
1 |
0.0156 |
| 17 |
PURPLE GLOVE SYNDROME |
2 |
0.0153 |
| 18 |
ALCOHOLIC SEIZURE |
1 |
0.0135 |
| 19 |
EAR INFECTION VIRAL |
2 |
0.0125 |
| 20 |
ZINC DEFICIENCY |
2 |
0.0093 |
| 21 |
IIIRD NERVE DISORDER |
1 |
0.0070 |
| 22 |
BRUCELLOSIS |
1 |
0.0066 |
| 23 |
NEUROSYPHILIS |
1 |
0.0066 |
| 24 |
NEONATAL BEHAVIOURAL SYNDROME |
2 |
0.0065 |
| 25 |
NECROSIS ISCHAEMIC |
3 |
0.0065 |
| 26 |
PROTEIN DEFICIENCY |
2 |
0.0064 |
| 27 |
GASTROENTERITIS ADENOVIRUS |
1 |
0.0064 |
| 28 |
GASTROENTERITIS EOSINOPHILIC |
2 |
0.0059 |
| 29 |
GENITALIA EXTERNAL AMBIGUOUS |
1 |
0.0058 |
| 30 |
CHRONIC RESPIRATORY DISEASE |
2 |
0.0057 |
| 31 |
EXAGGERATED STARTLE RESPONSE |
1 |
0.0055 |
| 32 |
RETINOPATHY OF PREMATURITY |
3 |
0.0054 |
| 33 |
HAEMOFILTRATION |
1 |
0.0053 |
| 34 |
HERPES SIMPLEX TEST POSITIVE |
1 |
0.0050 |
| 35 |
VESICOURETERIC REFLUX |
2 |
0.0049 |
| 36 |
ABNORMAL CLOTTING FACTOR |
1 |
0.0049 |
| 37 |
POSTICTAL STATE |
5 |
0.0048 |
| 38 |
RENAL VESSEL DISORDER |
1 |
0.0047 |
| 39 |
OCULOMUCOCUTANEOUS SYNDROME |
2 |
0.0047 |
| 40 |
MULTIPLE-DRUG RESISTANCE |
13 |
0.0042 |
| 41 |
BRONCHOPULMONARY DYSPLASIA |
3 |
0.0037 |
| 42 |
SCLERAL DISORDER |
1 |
0.0037 |
| 43 |
INTRAVENTRICULAR HAEMORRHAGE |
9 |
0.0036 |
| 44 |
INCISION SITE PAIN |
4 |
0.0034 |
| 45 |
GASTRIC HYPOMOTILITY |
1 |
0.0033 |
| 46 |
EPIDERMOLYSIS BULLOSA |
1 |
0.0032 |
| 47 |
MUCOSAL ULCERATION |
3 |
0.0030 |
| 48 |
HEART INJURY |
7 |
0.0028 |
| 49 |
OTITIS MEDIA ACUTE |
2 |
0.0027 |
| 50 |
ENTEROBACTER SEPSIS |
1 |
0.0027 |
| 51 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
1 |
0.0025 |
| 52 |
INHIBITORY DRUG INTERACTION |
4 |
0.0025 |
| 53 |
PERSISTENT DEPRESSIVE DISORDER |
1 |
0.0025 |
| 54 |
INFANTILE APNOEA |
2 |
0.0025 |
| 55 |
OESOPHAGEAL DISORDER |
9 |
0.0023 |
| 56 |
GLIOSIS |
1 |
0.0023 |
| 57 |
TEMPORAL LOBE EPILEPSY |
1 |
0.0023 |
| 58 |
FACIAL NERVE DISORDER |
1 |
0.0023 |
| 59 |
FEEDING INTOLERANCE |
1 |
0.0022 |
| 60 |
MUSCLE MASS |
1 |
0.0022 |
| 61 |
SEXUALLY INAPPROPRIATE BEHAVIOUR |
1 |
0.0021 |
| 62 |
POSTOPERATIVE INFECTION |
1 |
0.0021 |
| 63 |
RED BLOOD CELLS URINE POSITIVE |
2 |
0.0021 |
| 64 |
BLOOD URIC ACID DECREASED |
1 |
0.0021 |
| 65 |
TONGUE DISCOLOURATION |
9 |
0.0021 |
| 66 |
ROOT CANAL INFECTION |
1 |
0.0020 |
| 67 |
EAR INJURY |
1 |
0.0020 |
| 68 |
SUPERINFECTION |
3 |
0.0020 |
| 69 |
CATARACT OPERATION COMPLICATION |
1 |
0.0020 |
| 70 |
TRACHEAL DISORDER |
1 |
0.0019 |
| 71 |
CONVULSION NEONATAL |
1 |
0.0019 |
| 72 |
ANAL STENOSIS |
1 |
0.0019 |
| 73 |
STATUS EPILEPTICUS |
21 |
0.0019 |
| 74 |
CRYSTALLURIA |
1 |
0.0018 |
| 75 |
PRESBYOPIA |
1 |
0.0018 |
| 76 |
BRAIN SCAN ABNORMAL |
1 |
0.0018 |
| 77 |
FOCAL DYSCOGNITIVE SEIZURES |
2 |
0.0018 |
| 78 |
ENTERAL NUTRITION |
1 |
0.0017 |
| 79 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
2 |
0.0017 |
| 80 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
2 |
0.0016 |
| 81 |
PROTHROMBIN TIME RATIO DECREASED |
1 |
0.0016 |
| 82 |
NECROTISING COLITIS |
2 |
0.0016 |
| 83 |
CHANGE IN SEIZURE PRESENTATION |
1 |
0.0015 |
| 84 |
ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0015 |
| 85 |
PAROTID GLAND ENLARGEMENT |
1 |
0.0015 |
| 86 |
TRIPLE NEGATIVE BREAST CANCER |
1 |
0.0015 |
| 87 |
PARANEOPLASTIC SYNDROME |
1 |
0.0015 |
| 88 |
NEURODEVELOPMENTAL DISORDER |
1 |
0.0015 |
| 89 |
WALKING DISABILITY |
3 |
0.0014 |
| 90 |
TONIC CONVULSION |
2 |
0.0014 |
| 91 |
FOETAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0014 |
| 92 |
INFANTILE SPASMS |
1 |
0.0014 |
| 93 |
APALLIC SYNDROME |
1 |
0.0014 |
| 94 |
ESCHAR |
1 |
0.0014 |
| 95 |
CEREBELLAR SYNDROME |
3 |
0.0014 |
| 96 |
BRAIN CONTUSION |
1 |
0.0014 |
| 97 |
BLISTER RUPTURE |
1 |
0.0013 |
| 98 |
HYPERTHERMIA MALIGNANT |
2 |
0.0013 |
| 99 |
ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0013 |
| 100 |
MYOCLONIC EPILEPSY |
2 |
0.0013 |
| 101 |
PULMONARY MYCOSIS |
1 |
0.0013 |
| 102 |
OPHTHALMOPLEGIA |
2 |
0.0013 |
| 103 |
LYMPHOCYTE STIMULATION TEST POSITIVE |
1 |
0.0012 |
| 104 |
ANTICONVULSANT DRUG LEVEL INCREASED |
2 |
0.0012 |
| 105 |
SEIZURE CLUSTER |
1 |
0.0012 |
| 106 |
MYOCARDIAL FIBROSIS |
1 |
0.0012 |
| 107 |
HEPATIC HAEMORRHAGE |
1 |
0.0012 |
| 108 |
ALCOHOL WITHDRAWAL SYNDROME |
1 |
0.0011 |
| 109 |
TESTICULAR ATROPHY |
1 |
0.0011 |
| 110 |
NYSTAGMUS |
6 |
0.0011 |
| 111 |
DRUG DETOXIFICATION |
1 |
0.0011 |
| 112 |
PSYCHOGENIC SEIZURE |
1 |
0.0011 |
| 113 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
4 |
0.0010 |
| 114 |
PETIT MAL EPILEPSY |
5 |
0.0010 |
| 115 |
PARTIAL SEIZURES |
5 |
0.0010 |
| 116 |
HYPOPERFUSION |
1 |
0.0010 |
| 117 |
ELECTROENCEPHALOGRAM ABNORMAL |
3 |
0.0009 |
| 118 |
LANGUAGE DISORDER |
2 |
0.0009 |
| 119 |
EPILEPSY |
27 |
0.0009 |
| 120 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
2 |
0.0009 |
| 121 |
BILIRUBIN CONJUGATED INCREASED |
2 |
0.0009 |
| 122 |
PNEUMONIA INFLUENZAL |
1 |
0.0008 |
| 123 |
UPPER RESPIRATORY TRACT INFLAMMATION |
1 |
0.0008 |
| 124 |
KIDNEY TRANSPLANT REJECTION |
4 |
0.0008 |
| 125 |
CARDIAC DEATH |
1 |
0.0008 |
| 126 |
FEBRILE CONVULSION |
1 |
0.0008 |
| 127 |
HAEMATOCRIT ABNORMAL |
1 |
0.0008 |
| 128 |
ORAL MUCOSA EROSION |
1 |
0.0008 |
| 129 |
NEUTROPHIL COUNT INCREASED |
8 |
0.0008 |
| 130 |
BILIARY TRACT DISORDER |
1 |
0.0007 |
| 131 |
AUDITORY DISORDER |
1 |
0.0007 |
| 132 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 133 |
RED BLOOD CELL COUNT ABNORMAL |
1 |
0.0007 |
| 134 |
APRAXIA |
1 |
0.0007 |
| 135 |
METABOLIC ENCEPHALOPATHY |
2 |
0.0007 |
| 136 |
PALLOR |
18 |
0.0007 |
| 137 |
CALCULUS URINARY |
1 |
0.0006 |
| 138 |
RESUSCITATION |
1 |
0.0006 |
| 139 |
HIGH DENSITY LIPOPROTEIN DECREASED |
2 |
0.0006 |
| 140 |
HYPERAMMONAEMIA |
3 |
0.0006 |
| 141 |
HEPATORENAL SYNDROME |
1 |
0.0006 |
| 142 |
SEIZURE |
68 |
0.0006 |
| 143 |
DRUG RESISTANCE |
15 |
0.0006 |
| 144 |
GRANULOMA |
2 |
0.0006 |
| 145 |
THYROIDECTOMY |
1 |
0.0006 |
| 146 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
1 |
0.0006 |
| 147 |
HYPERREFLEXIA |
2 |
0.0006 |
| 148 |
BLOOD LACTIC ACID INCREASED |
3 |
0.0006 |
| 149 |
DRUG WITHDRAWAL CONVULSIONS |
1 |
0.0006 |
| 150 |
PRODUCT CONTAMINATION |
2 |
0.0006 |
| 151 |
INTESTINAL ISCHAEMIA |
3 |
0.0005 |
| 152 |
PUPILLARY REFLEX IMPAIRED |
1 |
0.0005 |
| 153 |
NASAL OBSTRUCTION |
1 |
0.0005 |
| 154 |
CLEFT PALATE |
1 |
0.0005 |
| 155 |
TRAUMATIC LUNG INJURY |
1 |
0.0005 |
| 156 |
BICYTOPENIA |
1 |
0.0005 |
| 157 |
PYELONEPHRITIS ACUTE |
1 |
0.0005 |
| 158 |
PNEUMONIA STAPHYLOCOCCAL |
1 |
0.0005 |
| 159 |
GENE MUTATION |
1 |
0.0005 |
| 160 |
GASTROINTESTINAL PERFORATION |
2 |
0.0005 |
| 161 |
HYPERPYREXIA |
2 |
0.0005 |
| 162 |
OCULOGYRIC CRISIS |
1 |
0.0005 |
| 163 |
HEPATIC LESION |
2 |
0.0005 |
| 164 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
1 |
0.0004 |
| 165 |
CHRONIC GASTRITIS |
1 |
0.0004 |
| 166 |
ACUTE GRAFT VERSUS HOST DISEASE |
2 |
0.0004 |
| 167 |
MYOPIA |
1 |
0.0004 |
| 168 |
MYOCLONUS |
5 |
0.0004 |
| 169 |
HYPOTONIA |
4 |
0.0004 |
| 170 |
DERMATITIS EXFOLIATIVE |
2 |
0.0004 |
| 171 |
LYMPHOCYTE COUNT DECREASED |
7 |
0.0004 |
| 172 |
HEPATOSPLENOMEGALY |
1 |
0.0004 |
| 173 |
PULMONARY HAEMORRHAGE |
3 |
0.0004 |
| 174 |
HEPATIC FUNCTION ABNORMAL |
14 |
0.0004 |
| 175 |
ALCOHOL POISONING |
1 |
0.0004 |
| 176 |
BEHAVIOUR DISORDER |
2 |
0.0004 |
| 177 |
CLONUS |
1 |
0.0004 |
| 178 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 179 |
DISSEMINATED INTRAVASCULAR COAGULATION |
5 |
0.0004 |
| 180 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 181 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
9 |
0.0003 |
| 182 |
SPEECH DISORDER DEVELOPMENTAL |
1 |
0.0003 |
| 183 |
COMA SCALE ABNORMAL |
1 |
0.0003 |
| 184 |
LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0003 |
| 185 |
COLD SWEAT |
6 |
0.0003 |
| 186 |
ATAXIA |
4 |
0.0003 |
| 187 |
URINE ANALYSIS ABNORMAL |
1 |
0.0003 |
| 188 |
LUNG ADENOCARCINOMA |
1 |
0.0003 |
| 189 |
ERYTHEMA MULTIFORME |
3 |
0.0003 |
| 190 |
SWOLLEN TONGUE |
10 |
0.0003 |
| 191 |
STEVENS-JOHNSON SYNDROME |
7 |
0.0003 |
| 192 |
PANCREATITIS ACUTE |
7 |
0.0003 |
| 193 |
SKIN EROSION |
1 |
0.0003 |
| 194 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
17 |
0.0003 |
| 195 |
POLYP |
2 |
0.0003 |
| 196 |
COLITIS ISCHAEMIC |
2 |
0.0003 |
| 197 |
DRUG LEVEL DECREASED |
3 |
0.0003 |
| 198 |
DUODENAL ULCER |
2 |
0.0003 |
| 199 |
DRUG ERUPTION |
5 |
0.0003 |
| 200 |
ALTERED STATE OF CONSCIOUSNESS |
6 |
0.0003 |
| 201 |
THROMBOCYTOSIS |
1 |
0.0003 |
| 202 |
UNRESPONSIVE TO STIMULI |
7 |
0.0003 |
| 203 |
TOXIC EPIDERMAL NECROLYSIS |
4 |
0.0003 |
| 204 |
HYPERTHERMIA |
2 |
0.0003 |
| 205 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 206 |
GASTRIC INFECTION |
1 |
0.0003 |
| 207 |
BACTERAEMIA |
3 |
0.0003 |
| 208 |
PNEUMOTHORAX |
4 |
0.0003 |
| 209 |
HYPERLIPIDAEMIA |
3 |
0.0003 |
| 210 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 211 |
RESPIRATORY DEPRESSION |
3 |
0.0002 |
| 212 |
HYPERURICAEMIA |
1 |
0.0002 |
| 213 |
ILEUS |
3 |
0.0002 |
| 214 |
COAGULOPATHY |
4 |
0.0002 |
| 215 |
DERMATITIS ALLERGIC |
3 |
0.0002 |
| 216 |
HAEMODIALYSIS |
2 |
0.0002 |
| 217 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 218 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 219 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
2 |
0.0002 |
| 220 |
URINE OUTPUT DECREASED |
2 |
0.0002 |
| 221 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 222 |
WHEELCHAIR USER |
1 |
0.0002 |
| 223 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 224 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
6 |
0.0002 |
| 225 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 226 |
THROMBOTIC MICROANGIOPATHY |
2 |
0.0002 |
| 227 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 228 |
VENOOCCLUSIVE LIVER DISEASE |
1 |
0.0002 |
| 229 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 230 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 231 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 232 |
SUBARACHNOID HAEMORRHAGE |
2 |
0.0002 |
| 233 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
2 |
0.0002 |
| 234 |
RESPIRATORY FAILURE |
14 |
0.0002 |
| 235 |
SERUM FERRITIN INCREASED |
1 |
0.0002 |
| 236 |
HALLUCINATION, VISUAL |
4 |
0.0002 |
| 237 |
ANAL FISTULA |
1 |
0.0002 |
| 238 |
BRUXISM |
1 |
0.0002 |
| 239 |
GINGIVITIS |
1 |
0.0002 |
| 240 |
HIP SURGERY |
1 |
0.0002 |
| 241 |
GENERALISED TONIC-CLONIC SEIZURE |
3 |
0.0002 |
| 242 |
CYTOMEGALOVIRUS INFECTION |
3 |
0.0002 |
| 243 |
GASTRIC ULCER HAEMORRHAGE |
1 |
0.0002 |
| 244 |
LIVER DISORDER |
8 |
0.0002 |
| 245 |
GRANULOCYTOPENIA |
1 |
0.0002 |
| 246 |
GASTRIC HAEMORRHAGE |
2 |
0.0002 |
| 247 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 248 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 249 |
HYPERCHLORHYDRIA |
1 |
0.0002 |
| 250 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
3 |
0.0002 |
| 251 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
1 |
0.0002 |
| 252 |
PLEURISY |
1 |
0.0002 |
| 253 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 254 |
INGUINAL HERNIA |
1 |
0.0002 |
| 255 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 256 |
SEPSIS |
18 |
0.0002 |
| 257 |
PRODUCT COMPLAINT |
4 |
0.0002 |
| 258 |
WHITE BLOOD CELL COUNT ABNORMAL |
1 |
0.0002 |
| 259 |
WHITE BLOOD CELL COUNT INCREASED |
6 |
0.0002 |
| 260 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 261 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 262 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 263 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 264 |
SOMNAMBULISM |
1 |
0.0002 |
| 265 |
HYPOGAMMAGLOBULINAEMIA |
1 |
0.0002 |
| 266 |
TOOTH INFECTION |
2 |
0.0002 |
| 267 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 268 |
ABORTION SPONTANEOUS |
6 |
0.0001 |
| 269 |
ILL-DEFINED DISORDER |
9 |
0.0001 |
| 270 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 271 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 272 |
ECCHYMOSIS |
1 |
0.0001 |
| 273 |
PERITONITIS |
3 |
0.0001 |
| 274 |
ENCEPHALITIS |
1 |
0.0001 |
| 275 |
LARGE INTESTINE POLYP |
1 |
0.0001 |
| 276 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 277 |
HYPOMAGNESAEMIA |
2 |
0.0001 |
| 278 |
HYPONATRAEMIA |
8 |
0.0001 |
| 279 |
HAND FRACTURE |
1 |
0.0001 |
| 280 |
AMNESIA |
9 |
0.0001 |
| 281 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 282 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 283 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
2 |
0.0001 |
| 284 |
PULMONARY MASS |
2 |
0.0001 |
| 285 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0001 |
| 286 |
BRADYCARDIA |
7 |
0.0001 |
| 287 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 288 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
1 |
0.0001 |
| 289 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 290 |
PELVIC FRACTURE |
1 |
0.0001 |
| 291 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 292 |
DRUG-INDUCED LIVER INJURY |
4 |
0.0001 |
| 293 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 294 |
MUSCLE DISORDER |
1 |
0.0001 |
| 295 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 296 |
ASPHYXIA |
1 |
0.0001 |
| 297 |
LIVER INJURY |
3 |
0.0001 |
| 298 |
ENCEPHALOPATHY |
3 |
0.0001 |
| 299 |
RHABDOMYOLYSIS |
5 |
0.0001 |
| 300 |
BLOOD UREA INCREASED |
2 |
0.0001 |
| 301 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0001 |
| 302 |
FACE OEDEMA |
2 |
0.0001 |
| 303 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 304 |
SCAR |
2 |
0.0001 |
| 305 |
ALANINE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 306 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 307 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 308 |
PLATELET COUNT DECREASED |
12 |
0.0001 |
| 309 |
CARDIOTOXICITY |
1 |
0.0001 |
| 310 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 311 |
LIMB INJURY |
3 |
0.0001 |
| 312 |
LIP DRY |
1 |
0.0001 |
| 313 |
LOSS OF CONSCIOUSNESS |
14 |
0.0001 |
| 314 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 315 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 316 |
APPENDICITIS |
1 |
0.0001 |
| 317 |
ATELECTASIS |
1 |
0.0001 |
| 318 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 319 |
PARKINSONISM |
1 |
0.0001 |
| 320 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 321 |
BRAIN INJURY |
1 |
0.0001 |
| 322 |
EMPHYSEMA |
1 |
0.0001 |
| 323 |
HYPOTHERMIA |
1 |
0.0001 |
| 324 |
TOOTH ABSCESS |
1 |
0.0001 |
| 325 |
MOUTH ULCERATION |
2 |
0.0001 |
| 326 |
SCRATCH |
1 |
0.0001 |
| 327 |
SUDDEN DEATH |
1 |
0.0001 |
| 328 |
ASPARTATE AMINOTRANSFERASE INCREASED |
5 |
0.0001 |
| 329 |
CONFUSIONAL STATE |
15 |
0.0001 |
| 330 |
BLOOD CREATININE INCREASED |
6 |
0.0001 |
| 331 |
OESOPHAGITIS |
1 |
0.0001 |
| 332 |
ASPIRATION |
1 |
0.0001 |
| 333 |
MELAENA |
2 |
0.0001 |
| 334 |
BLOOD PRESSURE DECREASED |
6 |
0.0001 |
| 335 |
NERVE INJURY |
1 |
0.0001 |
| 336 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 337 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 338 |
MALNUTRITION |
1 |
0.0001 |
| 339 |
DRUG INTERACTION |
14 |
0.0001 |
| 340 |
HAEMOGLOBIN DECREASED |
9 |
0.0001 |
| 341 |
SHOCK |
2 |
0.0001 |
| 342 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 343 |
SPLENOMEGALY |
1 |
0.0001 |
| 344 |
HYPOXIA |
3 |
0.0001 |
| 345 |
CHOLECYSTITIS |
1 |
0.0001 |
| 346 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 347 |
CYTOPENIA |
1 |
0.0001 |
| 348 |
PHARYNGITIS |
1 |
0.0001 |
| 349 |
BRAIN OEDEMA |
1 |
0.0001 |
| 350 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 351 |
MYDRIASIS |
1 |
0.0001 |
| 352 |
PRODUCT USE IN UNAPPROVED INDICATION |
19 |
0.0001 |
| 353 |
SEDATION |
2 |
0.0001 |
| 354 |
JAUNDICE |
2 |
0.0001 |
| 355 |
PNEUMONITIS |
2 |
0.0001 |
| 356 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 357 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 358 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
1 |
0.0001 |
| 359 |
TOXICITY TO VARIOUS AGENTS |
12 |
0.0001 |
| 360 |
SKIN REACTION |
1 |
0.0001 |
| 361 |
RENAL FAILURE ACUTE |
3 |
0.0001 |
| 362 |
HEART RATE INCREASED |
7 |
0.0001 |
| 363 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 364 |
ANGINA PECTORIS |
2 |
0.0001 |
| 365 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 366 |
HYPOKINESIA |
1 |
0.0001 |
| 367 |
OFF LABEL USE |
60 |
0.0001 |
| 368 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 369 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 370 |
HEPATIC FAILURE |
2 |
0.0001 |
| 371 |
APHASIA |
2 |
0.0001 |
| 372 |
OSTEOPENIA |
1 |
0.0001 |
| 373 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 374 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 375 |
RENAL DISORDER |
3 |
0.0001 |
| 376 |
COGNITIVE DISORDER |
3 |
0.0001 |
| 377 |
CYANOSIS |
1 |
0.0001 |
| 378 |
ARRHYTHMIA |
3 |
0.0001 |
| 379 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 380 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 381 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 382 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 383 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 384 |
LIP SWELLING |
2 |
0.0001 |
| 385 |
SKIN DISORDER |
2 |
0.0001 |
| 386 |
URINARY RETENTION |
2 |
0.0001 |
| 387 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 388 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 389 |
PRODUCT USE ISSUE |
11 |
0.0001 |
| 390 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 391 |
LOCAL SWELLING |
1 |
0.0001 |
| 392 |
HYPERKALAEMIA |
2 |
0.0001 |
| 393 |
GOUT |
1 |
0.0001 |
| 394 |
SOMNOLENCE |
11 |
0.0001 |
| 395 |
HYPERHIDROSIS |
7 |
0.0001 |
| 396 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 397 |
MEDICATION ERROR |
3 |
0.0001 |
| 398 |
BLISTER |
3 |
0.0001 |
| 399 |
DYSARTHRIA |
2 |
0.0001 |
| 400 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 401 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 402 |
CONDITION AGGRAVATED |
16 |
0.0001 |
| 403 |
ANAEMIA |
10 |
0.0001 |
| 404 |
CHOLESTASIS |
1 |
0.0001 |
| 405 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 406 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 407 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 408 |
DYSTONIA |
1 |
0.0001 |
| 409 |
NEUTROPENIA |
7 |
0.0001 |
| 410 |
EAR PAIN |
1 |
0.0001 |
| 411 |
CHOKING |
1 |
0.0001 |
| 412 |
DISABILITY |
1 |
0.0001 |
| 413 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 414 |
DISORIENTATION |
2 |
0.0001 |
| 415 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 416 |
PREGNANCY |
1 |
0.0000 |
| 417 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 418 |
DYSKINESIA |
2 |
0.0000 |
| 419 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 420 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 421 |
RIB FRACTURE |
1 |
0.0000 |
| 422 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 423 |
ABDOMINAL DISTENSION |
5 |
0.0000 |
| 424 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 425 |
EATING DISORDER |
1 |
0.0000 |
| 426 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 427 |
RECTAL HAEMORRHAGE |
2 |
0.0000 |
| 428 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 429 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 430 |
FALL |
15 |
0.0000 |
| 431 |
MATERNAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 432 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 433 |
ORAL PAIN |
1 |
0.0000 |
| 434 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 435 |
DRUG INEFFECTIVE |
58 |
0.0000 |
| 436 |
PYREXIA |
15 |
0.0000 |
| 437 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 438 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 439 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 440 |
PULMONARY EMBOLISM |
4 |
0.0000 |
| 441 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 442 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 443 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 444 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 445 |
PNEUMONIA |
13 |
0.0000 |
| 446 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 447 |
AGGRESSION |
2 |
0.0000 |
| 448 |
HAEMATEMESIS |
1 |
0.0000 |
| 449 |
HYPOPHAGIA |
1 |
0.0000 |
| 450 |
HEPATITIS |
1 |
0.0000 |
| 451 |
ERYTHEMA |
8 |
0.0000 |
| 452 |
ABDOMINAL PAIN UPPER |
8 |
0.0000 |
| 453 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 454 |
DIPLOPIA |
1 |
0.0000 |
| 455 |
DEAFNESS |
1 |
0.0000 |
| 456 |
GASTRITIS |
1 |
0.0000 |
| 457 |
CARDIAC FAILURE CONGESTIVE |
3 |
0.0000 |
| 458 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 459 |
BLOOD GLUCOSE INCREASED |
7 |
0.0000 |
| 460 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 461 |
FOETAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 462 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 463 |
OEDEMA |
2 |
0.0000 |
| 464 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 465 |
TREATMENT FAILURE |
3 |
0.0000 |
| 466 |
DIVERTICULITIS |
1 |
0.0000 |
| 467 |
DRUG ABUSE |
3 |
0.0000 |
| 468 |
HERPES ZOSTER |
2 |
0.0000 |
| 469 |
LETHARGY |
2 |
0.0000 |
| 470 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 471 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 472 |
TACHYCARDIA |
3 |
0.0000 |
| 473 |
RENAL INJURY |
1 |
0.0000 |
| 474 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 475 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 476 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 477 |
VERTIGO |
2 |
0.0000 |
| 478 |
ACUTE KIDNEY INJURY |
5 |
0.0000 |
| 479 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 480 |
CONSTIPATION |
7 |
0.0000 |
| 481 |
SWELLING |
3 |
0.0000 |
| 482 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 483 |
CONTUSION |
3 |
0.0000 |
| 484 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 485 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 486 |
CHOLELITHIASIS |
1 |
0.0000 |
| 487 |
FEBRILE NEUTROPENIA |
2 |
0.0000 |
| 488 |
RENAL FAILURE |
4 |
0.0000 |
| 489 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 490 |
HYPOTENSION |
6 |
0.0000 |
| 491 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 492 |
HAEMATURIA |
1 |
0.0000 |
| 493 |
ILLNESS |
3 |
0.0000 |
| 494 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 495 |
INJECTION SITE REACTION |
2 |
0.0000 |
| 496 |
NIGHTMARE |
1 |
0.0000 |
| 497 |
DELIRIUM |
1 |
0.0000 |
| 498 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 499 |
RASH MACULAR |
1 |
0.0000 |
| 500 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 501 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 502 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 503 |
DYSURIA |
1 |
0.0000 |
| 504 |
COLITIS |
1 |
0.0000 |
| 505 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 506 |
CARDIAC FAILURE |
2 |
0.0000 |
| 507 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 508 |
DRY MOUTH |
2 |
0.0000 |
| 509 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 510 |
TREMOR |
4 |
0.0000 |
| 511 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 512 |
PRODUCT DOSE OMISSION ISSUE |
7 |
0.0000 |
| 513 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 514 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 515 |
SEPTIC SHOCK |
1 |
0.0000 |
| 516 |
RASH |
10 |
0.0000 |
| 517 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 518 |
THROAT IRRITATION |
1 |
0.0000 |
| 519 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 520 |
TINNITUS |
1 |
0.0000 |
| 521 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 522 |
DECREASED APPETITE |
5 |
0.0000 |
| 523 |
CARDIAC DISORDER |
2 |
0.0000 |
| 524 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 525 |
COMA |
1 |
0.0000 |
| 526 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 527 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 528 |
LUNG DISORDER |
1 |
0.0000 |
| 529 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 530 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 531 |
INFLAMMATION |
1 |
0.0000 |
| 532 |
NERVOUSNESS |
1 |
0.0000 |
| 533 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 534 |
RASH PRURITIC |
1 |
0.0000 |
| 535 |
ARTHROPATHY |
1 |
0.0000 |
| 536 |
WEIGHT DECREASED |
5 |
0.0000 |
| 537 |
URTICARIA |
3 |
0.0000 |
| 538 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 539 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 540 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 541 |
DYSPHONIA |
1 |
0.0000 |
| 542 |
WHEEZING |
1 |
0.0000 |
| 543 |
CATARACT |
1 |
0.0000 |
| 544 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 545 |
IRRITABILITY |
1 |
0.0000 |
| 546 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 547 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 548 |
DISCOMFORT |
1 |
0.0000 |
| 549 |
DEATH |
14 |
0.0000 |
| 550 |
DIZZINESS |
8 |
0.0000 |
| 551 |
ASTHENIA |
6 |
0.0000 |
| 552 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 553 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 554 |
DEHYDRATION |
2 |
0.0000 |
| 555 |
VOMITING |
7 |
0.0000 |
| 556 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 557 |
COUGH |
4 |
0.0000 |
| 558 |
SLEEP DISORDER |
1 |
0.0000 |
| 559 |
HYPERTENSION |
3 |
0.0000 |
| 560 |
DYSPNOEA |
8 |
0.0000 |
| 561 |
OVERDOSE |
3 |
0.0000 |
| 562 |
HYPOAESTHESIA |
2 |
0.0000 |
| 563 |
DIABETES MELLITUS |
1 |
0.0000 |
| 564 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 565 |
HOSPITALISATION |
2 |
0.0000 |
| 566 |
PRURITUS |
5 |
0.0000 |
| 567 |
CARDIAC ARREST |
1 |
0.0000 |
| 568 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 569 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 570 |
BALANCE DISORDER |
1 |
0.0000 |
| 571 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 572 |
MUSCLE SPASMS |
2 |
0.0000 |
| 573 |
CHEST PAIN |
2 |
0.0000 |
| 574 |
DYSPHAGIA |
1 |
0.0000 |
| 575 |
DYSPEPSIA |
1 |
0.0000 |
| 576 |
FLUSHING |
1 |
0.0000 |
| 577 |
DIARRHOEA |
6 |
0.0000 |
| 578 |
FATIGUE |
7 |
0.0000 |
| 579 |
INFLUENZA |
1 |
0.0000 |
| 580 |
ASTHMA |
1 |
0.0000 |
| 581 |
CHILLS |
1 |
0.0000 |
| 582 |
JOINT SWELLING |
1 |
0.0000 |
| 583 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 584 |
INSOMNIA |
2 |
0.0000 |
| 585 |
DRY SKIN |
1 |
0.0000 |
| 586 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 587 |
VISION BLURRED |
1 |
0.0000 |
| 588 |
ANXIETY |
2 |
0.0000 |
| 589 |
INFECTION |
1 |
0.0000 |
| 590 |
MALAISE |
3 |
0.0000 |
| 591 |
PARAESTHESIA |
1 |
0.0000 |
| 592 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 593 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 594 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 595 |
COVID-19 |
1 |
0.0000 |
| 596 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 597 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 598 |
ALOPECIA |
1 |
0.0000 |
| 599 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 600 |
PAIN |
3 |
0.0000 |
| 601 |
WEIGHT INCREASED |
1 |
0.0000 |
| 602 |
DEPRESSION |
1 |
0.0000 |
| 603 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 604 |
BACK PAIN |
1 |
0.0000 |
| 605 |
FEELING ABNORMAL |
1 |
0.0000 |
| 606 |
NAUSEA |
3 |
0.0000 |
| 607 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 608 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 609 |
HEADACHE |
2 |
0.0000 |